SugenTech

SugenTech EBITDA per Employee

EBITDA per Employee of SugenTech (253840.KQ) as of Oct 17, 2026.

EBITDA per Employee

-KRW

Last updated:

EBITDA per Employee of SugenTech is 2026 - KRW. EBITDA per Employee of SugenTech was 2025 - KRW. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SugenTech Stock analysis

What does SugenTech do? SugenTech Inc., headquartered in Daejeon, South Korea, operates in the Health Care sector, specializing in in-vitro diagnostic systems and products. The company develops and sells diagnostic test reagents, point-of-care testing (POCT) products under INCLIX, and personal-use test kits under SUREARLY. It also manufactures folic acid products under SOLGAR and molecular diagnostic reagents. SugenTech distributes its offerings domestically and internationally, including in Indonesia, focusing on therapeutic drug monitoring and drug analysis method development. SugenTech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SugenTech stock

On Eulerpool you can find the complete historical development of EBITDA per Employee SugenTech since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's SugenTech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — SugenTech

All Key Metrics — SugenTech